These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 17934180

  • 21. Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
    Harpin VA.
    Arch Dis Child Educ Pract Ed; 2008 Apr; 93(2):58-65. PubMed ID: 18356307
    [Abstract] [Full Text] [Related]

  • 22. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH, Lee YS, Na C, Ahn JY, Chung US, Daniels MA, Haws CA, Renshaw PF.
    Compr Psychiatry; 2009 Apr; 50(3):251-6. PubMed ID: 19374970
    [Abstract] [Full Text] [Related]

  • 23. Pharmacological management of a youth with ADHD and a seizure disorder.
    Gonzalez-Heydrich J, Weiss M, Connolly M, Wambera K, Jan JE, Plioplys S, Dunn DW, Kratochvil CJ.
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1527-32. PubMed ID: 17135999
    [No Abstract] [Full Text] [Related]

  • 24. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder.
    Wilson HK, Cox DJ, Merkel RL, Moore M, Coghill D.
    Arch Clin Neuropsychol; 2006 Dec; 21(8):797-807. PubMed ID: 17049803
    [Abstract] [Full Text] [Related]

  • 25. Atomoxetine.
    Unni JC.
    Indian Pediatr; 2006 Jul; 43(7):603-6. PubMed ID: 16891679
    [No Abstract] [Full Text] [Related]

  • 26. Clinical considerations for the diagnosis and treatment of ADHD in the managed care setting.
    Jensen PS.
    Am J Manag Care; 2009 May; 15(5 Suppl):S129-40. PubMed ID: 19601688
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
    Hennessy S, Schelleman H, Daniel GW, Bilker WB, Kimmel SE, Guevara J, Cziraky MJ, Strom BL.
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):934-41. PubMed ID: 20623519
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dimensional analysis of ADHD subtypes in rats.
    Blondeau C, Dellu-Hagedorn F.
    Biol Psychiatry; 2007 Jun 15; 61(12):1340-50. PubMed ID: 17054922
    [Abstract] [Full Text] [Related]

  • 32. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P, Besana D, Mancini F, Rossi A, Poole L, Escobar R, Zuddas A, LYCY Study Group.
    Eur Neuropsychopharmacol; 2009 Nov 15; 19(11):822-34. PubMed ID: 19716683
    [Abstract] [Full Text] [Related]

  • 33. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.
    Toxicol Lett; 2009 Jan 10; 184(1):38-43. PubMed ID: 19015014
    [Abstract] [Full Text] [Related]

  • 34. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 35. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, Day M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan 01; 32(1):34-41. PubMed ID: 17714843
    [Abstract] [Full Text] [Related]

  • 36. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.
    Psychiatr Pol; 2009 Jan 01; 43(2):183-92. PubMed ID: 19697788
    [Abstract] [Full Text] [Related]

  • 37. Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD.
    Johnson KA, Barry E, Bellgrove MA, Cox M, Kelly SP, Dáibhis A, Daly M, Keavey M, Watchorn A, Fitzgerald M, McNicholas F, Kirley A, Robertson IH, Gill M.
    Neuropsychologia; 2008 Apr 01; 46(5):1532-41. PubMed ID: 18289615
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
    Sangal RB, Sangal JM.
    Clin Neurophysiol; 2006 Sep 01; 117(9):1996-2006. PubMed ID: 16890481
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.